Related references
Note: Only part of the references are listed.Matrix compliance permits NF-κB activation to drive therapy resistance in breast cancer
Allison P. Drain et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Matrix compliance permits NF-kappa B activation to drive therapy resistance in breast cancer
Allison P. Drain et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Old dogs, new trick: classic cancer therapies activate cGAS
Seoyun Yum et al.
CELL RESEARCH (2020)
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
Zefei Jiang et al.
LANCET ONCOLOGY (2019)
Cancer modeling meets human organoid technology
David Tuveson et al.
SCIENCE (2019)
Mechanism and medical implications of mammalian autophagy
Ivan Dikic et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing
Deng Pan et al.
SCIENCE (2018)
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple- negative breast cancer to immune checkpoint therapy
Marie-Claude Bourgeois-Daigneault et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Patient-derived tumor organoids for prediction of cancer treatment response
Peter W. Nagle et al.
SEMINARS IN CANCER BIOLOGY (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy
Silvia von Karstedt et al.
NATURE REVIEWS CANCER (2017)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Rita Nanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
Tze-Sian Chan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Late stages of T cell maturation in the thymus involve NF-κB and tonic type I interferon signaling
Yan Xing et al.
NATURE IMMUNOLOGY (2016)
Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation
Laura Broutier et al.
NATURE PROTOCOLS (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Type I interferons in anticancer immunity
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Xiaomei Zhang et al.
CANCER RESEARCH (2013)
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
Laurence Zitvogel et al.
IMMUNITY (2013)
A new method for high-resolution imaging of Ku foci to decipher mechanisms of DNA double-strand break repair
Sebastien Britton et al.
JOURNAL OF CELL BIOLOGY (2013)
Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis
Theresa Alenghat et al.
NATURE (2013)
Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo
Seo-Hee You et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses
Vladimir Litvak et al.
NATURE (2012)
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bradley N. Bidwell et al.
NATURE MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
Mark F. Ciaccio et al.
NATURE METHODS (2010)
Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
Jia-Lin Lee et al.
JOURNAL OF CELL BIOLOGY (2009)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses
Dirk Grimm et al.
JOURNAL OF VIROLOGY (2008)
Expansion and evolution of cell death programmes
Alexei Degterev et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Revisiting youden's index as a useful measure of the misclassification error in meta-analysis of diagnostic studies
Dankmar Bohning et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2008)
Integrative genornics analysis reveals silencing of β-adrenergic signaling by polycomb in prostate cancer
Jinclan Yu et al.
CANCER CELL (2007)
Elevated levee of SUMOylated IRF-1 on tumor cells interferes with IRF-1-mediated apoptosis
Junsoo Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells
M. T. Stang et al.
ONCOGENE (2007)
Three-dimensional culture models of normal and malignant breast epithelial cells
Genee Y. Lee et al.
NATURE METHODS (2007)
SOCS proteins, cytokine signalling and immune regulation
Akihiko Yoshimura et al.
NATURE REVIEWS IMMUNOLOGY (2007)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
Sergio A. Quezada et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
V Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis
KB Bouker et al.
CARCINOGENESIS (2005)
Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures
O Modlich et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors
A Codina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes
SJH Sui et al.
NUCLEIC ACIDS RESEARCH (2005)
Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL
N Clarke et al.
EMBO JOURNAL (2004)
Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin
E Pizzoferrato et al.
CANCER RESEARCH (2004)
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
JC Chang et al.
LANCET (2003)
The N-CoR/histone deacetylase 3 complex is required for repression by thyroid hormone receptor
T Ishizuka et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation
JJ Yu et al.
EMBO JOURNAL (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
β4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium
VM Weaver et al.
CANCER CELL (2002)
Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3
JW Li et al.
EMBO JOURNAL (2000)
Share Paper
